BayBio - BayBio2010 Partnering Forum

BayBio2010 will help large pharmaceutical companies to identify the most qualified biotech partners. It will provide small therapeutic, diagnostic and medical device companies an early access opportunity with the large pharmaceutical companies seeking to meet high quality potential partners and to add new product candidates and platform technologies to their pipelines.

Attendees from life sciences companies and investment community will have access tobiopartnering.com^TM, where they can research companies attending BayBio2010 conference, request meetings and connect with prospective partners. Two levels of partnering are offered in 2010:

Private Partnering Suites, available to Partnering Forum Sponsors.
Semi-Private Meetings in our Partnering Hall, available to general conference attendees

Grow your business by partnering:

Start your networking long before you arrive in San Francisco; don’t leave your deal making just to chance
Maximize the effectiveness of your networking by creating a structured plan of attack
Maximize your time at the conference, as there is no restriction on the number of meeting requests you can submit

By using biopartnering.com^(TM), you will be able to see who's attending the conference and participating in the Partnering Forum. You can contact them via email, bookmark them for later, or request a meeting. When they confirm the meeting, biopartnering.com^TM will automatically find a time and place for you to meet that works for both of you.

Key features of biopartnering.com^TM include:

Profiles - company, product and personal profiles that enable you to identify your objectives.
Searches - advanced and quick searches will assist you with reviewing the conference attendance list and identifying the best companies who would make great resources/partners. You will be able to save your searches so that the system automatically reruns them each time you login.
Prospects - the ability to bookmark your targets with ease and precision for seamless follow up
Scheduling - face-to-face automated meeting scheduling; invite your prospects to a meeting. As meeting invitations are confirmed, the system will schedule the meetings for you based on your availability.
Automated Rescheduling - a new feature that will enable you to reschedule a confirmed meeting to an alternate time.
Meeting Agenda - create your personalized event agenda that includes both meetings and conference activities.
Onsite Messaging and Scheduling - stay informed about your meeting and networking activities while at the event via SMS messaging and emails.
Follow up - we all know that the process of networking can be daunting, for that reason biopartnering.com^TM will be available to you for up to 1 month after the conference for follow up with those you met or might have missed.

Powered By:

Additional Resources:

To help prepare for BayBio2010, Bay Bio and BioCentury have teamed up to provide BayBio2010 pre-registrants free access to BCIQ: BioCentury Online Intelligence. BCIQ's Company, Financial and Pipeline Analyst modules allow you to easily access BioCentury's industry knowledge of more than 5,000 private and public companies, $240 billion in financings, and 10,000 biopharma products. Click here for access.

Bay Bio and Life Science Analytics have teamed up to provide complimentary access of MedTRACK for registered attendees of the meeting. MedTRACK is the most comprehensive database of over 18,000 global private and public biomedical companies. MedTRACK can assist you in: Tracking trends across the life sciences industry; Identifying partners and build your network in new markets and geographies; Performing due diligence and best practices analysis; Capturing best practices in regulatory approvals; Benchmarking deal values, venture funding, and footprint expansion; Creating strategies for future growth.

Partnering Forum Sponsors:
BayBio 2010 Partnering Forum

Partnering Forum Supporters:

AvidBiotics
Bayer HealthCare Pharmaceuticals
Genzyme Corporation
Merck & Co., Inc.
Procter & Gamble

Attending Companies:

As of 03.29.10

3M Drug Delivery Systems
Aardvark Medical
Abbott Laboratories Inc.
ABES Partners
Adamas Pharmaceuticals, Inc.
Affymax, Inc.
Affymetrix, Inc.
Alafi Capital
Alloy Ventures
Alexza Pharmaceuticals
Alta Partners
Amgen Inc.
Amgen Ventures
Amunix, Inc.
Anesiva, Inc.
AngioScore, Inc.
Anthera Pharmaceuticals‚ Inc.
ARYx Therapeutics
Astellas Venture Management LLC
AvidBiotics
Barclays Capital
Baxter Healthcare Corporation
Bay City Capital LLC
Bayer Healthcare
Bill & Melinda Gates Foundation
Biolog, Inc.
Bio-Rad Laboratories, Inc.
BioXiness Pharmaceuticals, Inc.
Burrill & Company
Catalyst Biosciences, Inc.
Cato Bioventures
Cepheid
Centella Biotechnologies, Inc.
Charter Life Sciences
Claremont Creek Ventures
CoMentis
Complete Genomics, Inc.
Concentric Medical, Inc.
Conceptus, Inc.
Continuum
Cook Pharmica
Corcept Therapeutics
CPC Scientific
Critical Perfusion
Cytokinetics, Inc.
CVAC Systems, Inc.
D.E. Shaw & Co., L.P.
Delta Pharma
DSM Biologics
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
Exelixis, Inc.
Ferghana Partners, Inc.
Five Prime Therapeutics, Inc.
FLG Partners, LLC
Genentech
Genetic Chemistry Inc.
Genomic Health, Inc.
Genzyme Corporation
Gilead Sciences
GIRUS Life Sciences, Inc.
GlycoRx Partners, LLC
Halozyme Therapeutics, Inc.
Hana Biosciences, Inc.
Houlihan Lokey
ICDD-sas
Inbiopro
inNexus Biotechology Inc.
Intel Capital
InterMune, Inc.
Inverseon
iRhythm Technologies
IRIX Pharmaceuticals, Inc.
Jazz Pharmaceuticals
Kai Pharmaceuticals
KaloBios Pharmaceuticals
Kleiner Perkins Caufield & Byers
Keiretsu Forum
Life Science Analytics, Inc.
MabVax
MedPanel
Metabolex, Inc.
Mologen AG
Montgomery & Co., LLC
MP Healthcare Venture Management Inc.
Nektar Therapeutics
NeoGuide Systems Inc.
Neugenesis Corporation
NeuMedics
NeurogesX, Inc.
Novartis Diagnostics
Novo Nordisk Inc
Novo Ventures (U.S.)
Omicia Inc.
Omniox, Inc.
Oncomed Pharmaceuticals
Onyx Pharmaceuticals, Inc.
Pacific Biosciences
PAC-LINK Bioventures
Paracor Medical, Inc.
Penwest Pharmaceutical
Perlegen Sciences, Inc.
Pfizer Inc.
Poniard Pharmaceuticals, Inc
Portola Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals
Progentech USA, Inc.
Prometheus Laboratories Inc.
QB3
QuantaLife, Inc
Renovis
Roche
Sand Hill Angels, LLC
Sangamo Biosciences, Inc.
SciClone Pharmaceuticals, Inc.
SciLucent
SEA Medical Systems, Inc.
Skyline Ventures
Single Cell Technology
Solazyme
Solidus Biosciences, Inc.
SpectroScape Inc.
Stanford University
SV Life Sciences
Synergy Life Science Partners
Synthetic Genomics
Takeda San Francisco, Inc.
Talima Therapeutics Inc.
Tethys Bioscience, Inc.
TetraQ
Theravance, Inc.
Thomas, McNerney & Partners
Topica Pharmaceuticals, Inc.
Torrey Pines Investments
UCSF
Valley Fever Solutions, Inc.
Vantage Point Venture Partners
VasoStitch
Venture Capital-Private Equity Roundtable
Versartis, Inc.
VitaPath Genetics
Xceleron Inc.
XenoPort
XOMA, LLC

BayBio 400 Oyster Point Blvd. Suite 221 South San Francisco CA 94080 Tel: (650) 871-7101